Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Oct;70(2):257–267. doi: 10.1111/j.1476-5381.1980.tb07931.x

Effects of ketamine on vascular smooth muscle function

BM Altura, BT Altura, Anthony Carella
PMCID: PMC2044334  PMID: 7426835

Abstract

1 In vitro studies were undertaken on rat aortic strips and portal vein segments to determine whether or not the amine-type anaesthetic, ketamine, can exert direct actions on vascular smooth muscle.

2 Ketamine was found to inhibit development of spontaneous mechanical activity and lower basal tension. This action took place with ketamine concentrations found in anaesthetic plasma concentrations, i.e., 1 × 10-5 to 2 × 10-4 M.

3 Ketamine (10-5 to 10-3 M) dose-dependently attenuated contractions induced by adrenaline, noradrenaline, angiotensin II, vasopressin and KCl. These inhibitory actions were observed with ketamine added either before or after the induced contractions.

4 Ca2+-induced contractions of K+-depolarized aortae and portal veins were also attenuated, dose-dependently, by ketamine.

5 In contrast to the above inhibitory actions, ketamine (2 × 10-6 to 1 × 10-4 M) was found to potentiate specifically 5-hydroxytryptamine(5-HT)-induced contractions of both aortic and venous smooth muscle. However, this was only observed if ketamine was added after 5-HT had initiated a contractile response.

6 All of the inhibitory, as well as 5-HT-potentiating, effects were completely, and almost immediately, reversed upon washing out the anaesthetic from the organ baths.

7 A variety of pharmacological antagonists failed to mimic or affect the inhibitory effects induced by ketamine.

8 These data suggest that rat plasma concentrations of ketamine commonly associated with induction of surgical anaesthesia can induce, directly, relaxation and contractile potentiation of vascular muscle.

9 These diverse findings may aid in explaining the well-known biphasic pressor actions of ketamine.

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams H. R., Parker J. L., Mathew B. P. The influence of ketamine on inotropic and chronotropic responsiveness of heart muscle. J Pharmacol Exp Ther. 1977 Apr;201(1):171–183. [PubMed] [Google Scholar]
  2. Altura B. M., Altura B. T. Differential effects of substrate depletion on drug-induced contractions of rabbit aorta. Am J Physiol. 1970 Dec;219(6):1698–1705. doi: 10.1152/ajplegacy.1970.219.6.1698. [DOI] [PubMed] [Google Scholar]
  3. Altura B. M., Altura B. T. Magnesium and contraction of arterial smooth muscle. Microvasc Res. 1974 Mar;7(2):145–155. doi: 10.1016/0026-2862(74)90001-6. [DOI] [PubMed] [Google Scholar]
  4. Altura B. M., Edgarian H., Altura B. T. Differential effects of ethanol and mannitol on contraction of arterial smooth muscle. J Pharmacol Exp Ther. 1976 May;197(2):352–361. [PubMed] [Google Scholar]
  5. Altura B. M. Sex as a factor influencing the responsiveness of arterioles to catecholamines. Eur J Pharmacol. 1972 Dec;20(3):261–265. doi: 10.1016/0014-2999(72)90183-5. [DOI] [PubMed] [Google Scholar]
  6. Azzaro A. J., Smith D. J. The inhibitory action of ketamine HC1 on [3H]5-hydroxytryptamine accumulation by rat brain synaptosomal-rich fractions: comparison with [3H]catecholamine and [3H]gamma-aminobutyric acid uptake. Neuropharmacology. 1977 May;16(5):349–356. doi: 10.1016/0028-3908(77)90072-7. [DOI] [PubMed] [Google Scholar]
  7. Bohr D. F. Vascular smooth muscle updated. Circ Res. 1973 Jun;32(6):665–672. doi: 10.1161/01.res.32.6.665. [DOI] [PubMed] [Google Scholar]
  8. Chang P., Chan K. E., Ganendran A. Cardiovascular effects of 2-(O-chlorophenyl)-2-methylaminocyclohexanone (CI-581) in rats. Br J Anaesth. 1969 May;41(5):391–395. doi: 10.1093/bja/41.5.391. [DOI] [PubMed] [Google Scholar]
  9. Clanachan A. S., McGrath J. C. Effects of ketamine on the peripheral autonomic nervous system of the rat. Br J Pharmacol. 1976 Oct;58(2):247–252. doi: 10.1111/j.1476-5381.1976.tb10402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clanachan A. S., McGrath J. C., MacKenzie J. E. Cardiovascular effects of ketamine in the pithed rat, rabbit and cat. Br J Anaesth. 1976 Oct;48(10):935–939. doi: 10.1093/bja/48.10.935. [DOI] [PubMed] [Google Scholar]
  11. Cohen M. L., Chan S. L., Way W. L., Trevor A. J. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology. 1973 Oct;39(4):370–376. doi: 10.1097/00000542-197310000-00003. [DOI] [PubMed] [Google Scholar]
  12. Cohen M. L., Trevor A. J. On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. J Pharmacol Exp Ther. 1974 May;189(2):351–358. [PubMed] [Google Scholar]
  13. Corssen G., Domino E. F. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg. 1966 Jan-Feb;45(1):29–40. [PubMed] [Google Scholar]
  14. DOMINO E. F., CHODOFF P., CORSSEN G. PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN. Clin Pharmacol Ther. 1965 May-Jun;6:279–291. doi: 10.1002/cpt196563279. [DOI] [PubMed] [Google Scholar]
  15. Dowdy E. G., Kaya K. Studies of the mechanism of cardiovascular responses to CI-581. Anesthesiology. 1968 Sep-Oct;29(5):931–943. doi: 10.1097/00000542-196809000-00014. [DOI] [PubMed] [Google Scholar]
  16. Edgarian H., Altura B. M. Ethanol and contraction of venous smooth muscle. Anesthesiology. 1976 Apr;44(4):311–317. doi: 10.1097/00000542-197604000-00009. [DOI] [PubMed] [Google Scholar]
  17. Fuller R. W., Snoddy H. D., Molloy B. B. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors. Psychopharmacol Commun. 1975;1(5):455–464. [PubMed] [Google Scholar]
  18. Godfraind T. Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. J Physiol. 1976 Aug;260(1):21–35. doi: 10.1113/jphysiol.1976.sp011501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Godfraind T., Kaba A. The role of calcium in the action of drugs on vascular smooth muscle. Arch Int Pharmacodyn Ther. 1972 Apr;196(Suppl):–35. [PubMed] [Google Scholar]
  20. Horwitz L. D. Effects of intravenous anesthetic agents on left ventricular function in dogs. Am J Physiol. 1977 Jan;232(1):H44–H48. doi: 10.1152/ajpheart.1977.232.1.H44. [DOI] [PubMed] [Google Scholar]
  21. Johnstone M. The cardiovascular effects of ketamine in man. Anaesthesia. 1976 Sep;31(7):873–882. doi: 10.1111/j.1365-2044.1976.tb11898.x. [DOI] [PubMed] [Google Scholar]
  22. MCCARTHY D. A., CHEN G., KAUMP D. H., ENSOR C. GENERAL ANESTHETIC AND OTHER PHARMACOLOGICAL PROPERTIES OF 2-(O-CHLOROPHENYL)-2-METHYLAMINO CYCLOHEXANONE HCL (CI-58L). J New Drugs. 1965 Jan-Feb;5(1):21–33. doi: 10.1002/j.1552-4604.1965.tb00219.x. [DOI] [PubMed] [Google Scholar]
  23. McGrath J. C., MacKenzie J. E. The effects of intravenous anaesthetics on the cardiovascular system of the rabbit. Br J Pharmacol. 1977 Oct;61(2):199–212. doi: 10.1111/j.1476-5381.1977.tb08405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Montel H., Starke K., Görlitz B. D., Schümann H. J. Tierexperimentelle Untersuchungen zur Wirkung des Ketamins auf periphere sympathische Nerven. Anaesthesist. 1973 Mar;22(3):111–116. [PubMed] [Google Scholar]
  25. Nedergaard O. A. Cocaine-like effect of ketamine on vascular adrenergic neurones. Eur J Pharmacol. 1973 Aug;23(2):153–161. doi: 10.1016/0014-2999(73)90051-4. [DOI] [PubMed] [Google Scholar]
  26. Ochsner A. J., 3rd Cardiovascular and respiratory responses to ketamine hydrochloride in the rhesus monkey (Macaca mulatta). Lab Anim Sci. 1977 Feb;27(1):69–71. [PubMed] [Google Scholar]
  27. Traber D. L., Wilson R. D. Involvement of the sympathetic nervous system in the pressor response to ketamine. Anesth Analg. 1969 Mar-Apr;48(2):248–252. [PubMed] [Google Scholar]
  28. Traber D. L., Wilson R. D., Priano L. L. Differentiation of the cardiovascular effects of CI-581. Anesth Analg. 1968 Nov-Dec;47(6):769–778. [PubMed] [Google Scholar]
  29. Traber D. L., Wilson R. D., Priano L. L. The effect of alpha-adrenergic blockade on the cardiopulmonary response to ketamine. Anesth Analg. 1971 Sep-Oct;50(5):737–742. doi: 10.1213/00000539-197150050-00010. [DOI] [PubMed] [Google Scholar]
  30. Turlapaty P. D., Altura B. T., Altura B. M. Ethanol reduces Ca2+ concentrations in arterial and venous smooth muscle. Experientia. 1979 May 15;35(5):639–640. doi: 10.1007/BF01960370. [DOI] [PubMed] [Google Scholar]
  31. Van Breemen C., Farinas B. R., Gerba P., McNaughton E. D. Excitation-contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ Res. 1972 Jan;30(1):44–54. doi: 10.1161/01.res.30.1.44. [DOI] [PubMed] [Google Scholar]
  32. Virtue R. W., Alanis J. M., Mori M., Lafargue R. T., Vogel J. H., Metcalf D. R. An anesthetic agent: 2-orthochlorophenyl, 2-methylamino cyclohexanone HCl (CI-581). Anesthesiology. 1967 Sep-Oct;28(5):823–833. doi: 10.1097/00000542-196709000-00008. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES